Skip to main content

Table 1 Basic clinical characteristics of the study participants

From: Non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio serve as a predictor for coronary collateral circulation in chronic total occlusive patients

Variables

CCC good formation group (n = 144)

CCC poor formation group (n = 209)

P value

Age

63.27 ± 10.78

61.52 ± 12.16

0.165

Gender [man (%)]

122 (41.9)

169 (58.1)

0.349

Smoking

69 (41.3)

98 (58.7)

0.914

Diabetes

38 (38.0)

62 (62.0)

0.549

Hypertension

95 (43.6)

123 (56.4)

0.183

Coronary artery disease

3 (33.3)

6 (66.7)

0.645

drinking

41 (41.4)

58 (58.6)

0.904

aspirin

4 (33.3)

8 (66.7)

0.768

β-blockers

8 (38.1)

13 (61.9)

0.795

ACEI/ARB

22 (34.4)

42 (65.6)

0.264

TC (mmol/l)

4.40 ± 1.01

4.56 ± 1.13

0.179

TG (M (P25, P75), mmoL/L)

1.76 (0.97,2.10)

2.16 (1.12,2.35)

0.058

HDL (mmol/l)

1.07 (0.86,1.23)

0.97 (0.80,1.11)

0.002**

LDL (mmol/l)

2.73 ± 0.77

2.83 ± 0.87

0.251

LP(a)(M, mg/L)

219.65 (60.57,276.3)

184.56 (65.7,221)

0.288

Non-HDL-C (mmol/l)

3.33 (2.69,3.90)

3.59 (2.75,4.30)

0.057

Non-HDL-C/HDL

3.31 ± 1.22

3.86 ± 1.40

0.000*

Occlusive vessel (%)

   

Multiple vessels lesions

30 (62.5)

18 (37.5)

0.001*

LAD

39 (38.2)

63 (61.8)

0.552

LCX

21 (28.4)

53 (71.6)

0.015**

RCA

54 (41.9)

75 (58.1)

0.757

  1. CCC, coronary collateral circulation; ACEI, angiotension converting enzyme inhibitors;ARB, angiotensin receptor blocker; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; non-HDL-C, non–high-density lipoprotein cholesterol; TC/HDL, total cholesterol /high-density lipoprotein cholesterol ratio; Non-HDL-C/HDL, non–high-density lipoprotein cholesterol /high-density lipoprotein cholesterol ratio; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery
  2. *P < 0.01, **P < 0.05